Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma-Reference-Cited by-同舟云学术

Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma

Published:2015-09 Issue:9 Volume:5 Page:e349-e349
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Ozaki S,Handa H,Saitoh T,Murakami H,Itagaki M,Asaoku H,Suzuki K,Isoda A,Matsumoto M,Sawamura M,Konishi J,Sunami K,Takezako N,Hagiwara S,Kuroda Y,Chou T,Nagura E,Shimizu K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201579.pdf

Reference15 articles.

1. Palumbo A, Anderson K . Multiple myeloma. N Engl J Med 2011; 364: 1046–1060.

2. Kim K, Lee JH, Kim JS, Min CK, Yoon SS, Shimizu K et al. Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study. Am J Hematol 2014; 89: 751–756.

3. Cancer Information Service, National Cancer Center, Japan 2015.

4. San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M et al. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med 2008; 359: 906–917.

5. Sonneveld P, Goldschmidt H, Rosinol L, Blade J, Lahuerta JJ, Cavo M et al. Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: a meta-analysis of phase III randomized, controlled trials. J Clin Oncol 2013; 31: 3279–3287.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3;Japanese Journal of Clinical Oncology;2024-05-24

2. Discovery of cytotoxic truncated vitamin D derivatives against both bortezomib‐sensitive and bortezomib‐resistant multiple myeloma phenotypes;Medicinal Chemistry Research;2024-05

3. Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021);International Journal of Hematology;2024-03-29

4. Molecular genetic aberrations in the pathogenesis of multiple myeloma;Asian Biomedicine;2023-08-01

5. I. Symptoms and Basics of Diagnostic Approach in Multiple Myeloma: When and How ?;Nihon Naika Gakkai Zasshi;2023-07-10